Hind Mellah
20 august 1953 Hospital, Casablanca
About the Ocular Oncology and Pathology Session
Ocular Oncology and Pathology focuses on benign and malignant lesions involving the eye, orbit, eyelids, and surrounding tissues. The session connects clinical diagnosis with pathology, imaging, molecular characterization, biomarkers, medical and surgical treatment, radiation therapy, and evolving strategies for preserving vision and improving cancer outcomes.
Abstract Scope and Participation
Submissions may explore ocular tumors, orbital and eyelid malignancies, pathology, tumor imaging, biomarkers, molecular diagnostics, treatment approaches, prognosis, and survivorship. Ophthalmic oncologists, pathologists, ophthalmologists, researchers, radiation specialists, medical oncologists, and multidisciplinary cancer-care professionals are encouraged to participate.
Topics Covered in Ocular Oncology and Pathology
Topic 01
Ocular Tumors
Topic 02
Orbital Tumors
Topic 03
Retinal Tumors
Topic 04
Ophthalmic Pathology
Topic 05
Cancer Biomarkers
Topic 06
Ocular Cancer Therapy
Featured Speakers — Ocular Oncology and Pathology 2027
Browse all speakers →
Recent Research Presented at Ocular Oncology and Pathology Sessions
Circumscribed choroidal hemangioma presenting with acute metamorphopsia and exudative maculopathy: A case report
Background: Circumscribed Choroidal Hemangioma (CCH) is a benign vascular hamartoma of the choroid that may be detected in adulthood when exudation causes subretinal fluid and macular edema. Because…
Ciliary body melanoma revealed by painful ocular hypertension: An unusual clinical presentation (a case report)
Background : Ciliary body melanoma is a rare intraocular malignancy, accounting for less than 5% of uveal melanomas. Due to its retro iridal location and late functional manifestations, diagnosis may…
More than a cataract: Choroidal melanoma diagnosed on B-scan ultrasonography following an abnormal pre-operative examination
Background: Choroidal melanoma is the most common primary intraocular malignancy in adults, arising from melanocytes within the uveal tract. It makes up to 90% uveal melanomas, followed by tumours of…
Epidemiology and prognostic factors for survivals of patients with primary ocular adnexal lymphoma in Southern Thailand
Objective: To identify the clinical characteristics and prognosis of patients with primary Ocular Adnexal Lymphoma (OAL) in Southern Thailand. Methods: A retrospective case series in a tertiary-care…
Sac swelling doesn’t regurge: No time to relax
Objective: Lacrimal sac tumors are extremely rare. Most common benign tumor being squamous papilloma. Herein we present two unusual cases of benign lacrimal sac tumors with aim to highlight their…
Diagnostic uncertainty with a patient presenting with raised intra-ocular pressure. A unique case of choroidal melanoma
Introduction: This case report discusses a patient presenting with elevated Intraocular Pressure (IOP) unresponsive to oral or intravenous treatment, necessitating urgent cyclodiode intervention.…
Related Scientific Sessions at IOC 2027
Why Attend the Ocular Oncology and Pathology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Ocular Oncology and Pathology work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Ocular Oncology and Pathology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Ocular Oncology and Pathology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ocular Oncology and Pathology Conference 2027 — FAQs
What is the Ocular Oncology and Pathology track at IOC 2027?
The Ocular Oncology and Pathology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Oncology and Pathology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ocular Oncology and Pathology sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Oncology and Pathology are all welcome — whether presenting or attending.
Can I present my research in the Ocular Oncology and Pathology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ocular Oncology and Pathology sessions?
Yes. IOC 2027 is a hybrid conference — attend the Ocular Oncology and Pathology track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.